CORC

在结果中检索

CORC

浏览/检索结果: 共26条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Olaparib maintenance monotherapy in Chinese patients with platinum-sensitive relapsed ovarian cancer: China cohort from the phase III SOLO2 trial 期刊论文
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022
作者:  Liu, Jihong;  Yin, Rutie;  Wu, Lingying;  Zhu, Jianqing;  Lou, Ge
收藏  |  浏览/下载：31/0  |  提交时间：2022/05/05
The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer 期刊论文
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2020, 卷号: 39
作者:  Ma, Liying;  Bian, Xing;  Lin, Wenchu
收藏  |  浏览/下载：38/0  |  提交时间：2020/11/30
Olaparib induced senescence under P16 or P53 dependent manner in ovarian cancer 期刊论文
JOURNAL OF GYNECOLOGIC ONCOLOGY, 2019, 卷号: 30, 期号: 2
作者:  Wang, Zehua;  Gao, Jianwen;  Zhou, Jiabing;  Liu, Haiou;  Xu, Congjian
收藏  |  浏览/下载：24/0  |  提交时间：2019/12/05
MUS81 Inhibition Increases the Sensitivity to Therapy Effect in Epithelial Ovarian Cancer via Regulating CyclinB Pathway 期刊论文
JOURNAL OF CANCER, 2019, 卷号: 10, 期号: 10
作者:  Zhong, Ailing;  Zheng, Hui;  Zhang, Hongqin;  Sun, Jiajun;  Shen, Jiabin
收藏  |  浏览/下载：34/0  |  提交时间：2019/12/05
SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer 期刊论文
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 卷号: 12
作者:  Lv, Hong;  Li, Ming;  Li, Anqi;  Zhou, Shuling;  Yang, Wentao
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05
Efficacy and safety of olaparib maintenance therapy in platinum-sensitive ovarian cancer patients with BRCA mutations: a meta-analysis on randomized controlled trials 期刊论文
CANCER MANAGEMENT AND RESEARCH, 2019, 卷号: 11
作者:  Deng, Hongyong;  Li, Jiajia;  Hu, Shaopu;  Yang, Yanping;  Ma, Jiao
收藏  |  浏览/下载：16/0  |  提交时间：2019/12/05
Synthesis, preliminarily biological evaluation and molecular docking study of new Olaparib analogues as multifunctional PARP-1 and cholinesterase inhibitors 期刊论文
Journal of enzyme inhibition and medicinal chemistry, 2019, 卷号: 34, 页码: 150-162
作者:  Gao Cheng-Zhi[1];  Dong Wei[2];  Cui Zhi-Wen[3];  Yuan Qiong[4];  Hu Xia-Min[5]
收藏  |  浏览/下载：33/0  |  提交时间：2019/04/22
Cyclin D1 silencing impairs DNA double strand break repair, sensitizes BRCA1 wildtype ovarian cancer cells to olaparib 期刊论文
Gynecologic Oncology, 2019, 卷号: Vol.152 No.1, 页码: 157-165
作者:  Qian Zhong;  Zhongyi Hu;  Qiao Li;  Tao Yi;  Jinke Li
收藏  |  浏览/下载：8/0  |  提交时间：2019/02/25
Synthesis, preliminarily biological evaluation and molecular docking study of new Olaparib analogues as multifunctional PARP-1 and cholinesterase inhibitors 期刊论文
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2019, 卷号: 34, 期号: 1
作者:  Gao, Cheng-Zhi;  Dong, Wei;  Cui, Zhi-Wen;  Yuan, Qiong;  Hu, Xia-Min
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/06
Patient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trial 期刊论文
2019, 卷号: 120, 页码: 20-30
作者:  Robson Mark;  Ruddy Kathryn J;  Im Seock-Ah;  Senkus Elżbieta;  Xu Binghe
收藏  |  浏览/下载：21/0  |  提交时间：2020/01/03

©版权所有 ©2017 CSpace - Powered by CSpace